DK1874762T3 - Fremgangsmåde til fremstilling af 5-(4-[4-(5-cyano-3-indolyl)-butyl]-1-piperazinyl)-benzofuran-2-carboxamid - Google Patents

Fremgangsmåde til fremstilling af 5-(4-[4-(5-cyano-3-indolyl)-butyl]-1-piperazinyl)-benzofuran-2-carboxamid

Info

Publication number
DK1874762T3
DK1874762T3 DK06724257T DK06724257T DK1874762T3 DK 1874762 T3 DK1874762 T3 DK 1874762T3 DK 06724257 T DK06724257 T DK 06724257T DK 06724257 T DK06724257 T DK 06724257T DK 1874762 T3 DK1874762 T3 DK 1874762T3
Authority
DK
Denmark
Prior art keywords
butyl
acid
benzofuran
carboxamide
piperazinyl
Prior art date
Application number
DK06724257T
Other languages
English (en)
Inventor
Andreas Bathe
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Application granted granted Critical
Publication of DK1874762T3 publication Critical patent/DK1874762T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/84—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D307/85—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/84—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Indole Compounds (AREA)
  • Furan Compounds (AREA)
DK06724257T 2005-04-26 2006-04-12 Fremgangsmåde til fremstilling af 5-(4-[4-(5-cyano-3-indolyl)-butyl]-1-piperazinyl)-benzofuran-2-carboxamid DK1874762T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005019670A DE102005019670A1 (de) 2005-04-26 2005-04-26 Verfahren zur Herstellung von (5-(4-[4-(5-Cyano-3-indolyl)-butyl)-1-piperazinyl)-benzofuran-2-carboxamid
PCT/EP2006/003344 WO2006114202A1 (de) 2005-04-26 2006-04-12 Verfahren zur herstellung von 5-(4-[4-(5-cyano-3-indolyl)-butyl]-1-piperazinyl)-benzofuran-2-carboxamid

Publications (1)

Publication Number Publication Date
DK1874762T3 true DK1874762T3 (da) 2009-04-14

Family

ID=36603535

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06724257T DK1874762T3 (da) 2005-04-26 2006-04-12 Fremgangsmåde til fremstilling af 5-(4-[4-(5-cyano-3-indolyl)-butyl]-1-piperazinyl)-benzofuran-2-carboxamid

Country Status (21)

Country Link
US (1) US7799916B2 (da)
EP (1) EP1874762B1 (da)
JP (2) JP5113039B2 (da)
KR (1) KR101310191B1 (da)
CN (1) CN101163698B (da)
AT (1) ATE420875T1 (da)
AU (1) AU2006239569B2 (da)
BR (2) BRPI0610336B8 (da)
CA (1) CA2605758A1 (da)
CY (1) CY1108904T1 (da)
DE (2) DE102005019670A1 (da)
DK (1) DK1874762T3 (da)
ES (1) ES2320172T3 (da)
HK (1) HK1116492A1 (da)
MX (1) MX2007013258A (da)
PL (1) PL1874762T3 (da)
PT (1) PT1874762E (da)
RU (1) RU2397981C2 (da)
SI (1) SI1874762T1 (da)
WO (1) WO2006114202A1 (da)
ZA (1) ZA200710145B (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102267985B (zh) * 2011-06-15 2015-12-09 上海医药工业研究院 维拉佐酮或其盐酸盐的制备方法
CN102267932A (zh) * 2011-06-15 2011-12-07 上海医药工业研究院 4-(5-氰基-1h-吲哚-3-基)丁基取代磺酸酯类化合物及其应用
CN102949364A (zh) * 2011-08-30 2013-03-06 天津药物研究院 一种含有效成分盐酸维拉佐酮的缓释片
EP2809665A1 (en) * 2012-02-01 2014-12-10 Ranbaxy Laboratories Limited Process for the preparation of vilazodone or its pharmaceutically acceptable salts
WO2013168126A1 (en) 2012-05-11 2013-11-14 Dr.Reddys Laboratories Limited Crystalline forms of vilazodone hydrochloride and vilazodone free base
WO2013175361A1 (en) * 2012-05-24 2013-11-28 Ranbaxy Laboratories Limited Process for the preparation of vilazodone hydrochloride
CN102796037B (zh) * 2012-08-09 2013-11-06 成都苑东药业有限公司 一种3-(4-(4-取代哌嗪)-1-丁酰基)吲哚-5-甲腈及其用途
WO2014028473A1 (en) * 2012-08-13 2014-02-20 Assia Chemical Industries Ltd. New salts of vilazodone and solid state forms thereof
CN102875538A (zh) * 2012-10-16 2013-01-16 北京诚创思达医药科技有限公司 维拉唑酮或其盐酸盐的制备方法
WO2014061004A2 (en) * 2012-10-19 2014-04-24 Ranbaxy Laboratories Limited Process for the preparation of vilazodone or pharmaceutically acceptable salt thereof
WO2014064715A2 (en) * 2012-10-22 2014-05-01 Cadila Healthcare Limited Amorphous form of vilazodone hydrochloride and process for preparing thereof
WO2014199313A1 (en) 2013-06-12 2014-12-18 Lupin Limited Substantially pure vilazodone hydrochloride and a process thereof
CN105017233A (zh) * 2014-04-23 2015-11-04 天津药物研究院 一种盐酸维拉佐酮晶体、其制备方法、药物组合物和用途
CN103965148B (zh) * 2014-05-15 2016-04-06 北京北陆药业股份有限公司 一种5-(哌嗪-1-基)苯并呋喃-2-羧酸乙酯的合成方法
CN107501159B (zh) * 2017-08-14 2020-11-24 连云港恒运药业有限公司 维拉佐酮中间体3-(4-氯丁基)-5-氰基吲哚合成方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4333254A1 (de) 1993-09-30 1995-04-06 Merck Patent Gmbh Piperidine und Piperazine
DE19514567A1 (de) * 1995-04-20 1996-10-24 Merck Patent Gmbh Benzofurane
DE10217006A1 (de) * 2002-04-16 2003-11-06 Merck Patent Gmbh Substituierte Indole
DE10252102A1 (de) * 2002-11-08 2004-05-27 Merck Patent Gmbh Indolderivate

Also Published As

Publication number Publication date
MX2007013258A (es) 2008-01-22
JP2012255005A (ja) 2012-12-27
SI1874762T1 (sl) 2009-04-30
WO2006114202A1 (de) 2006-11-02
JP5735465B2 (ja) 2015-06-17
JP2008539178A (ja) 2008-11-13
BR122020011626B8 (pt) 2021-07-27
DE502006002659D1 (de) 2009-03-05
ATE420875T1 (de) 2009-01-15
US7799916B2 (en) 2010-09-21
AU2006239569B2 (en) 2012-04-12
BRPI0610336B1 (pt) 2020-09-24
HK1116492A1 (en) 2008-12-24
KR101310191B1 (ko) 2013-09-24
ES2320172T3 (es) 2009-05-19
BRPI0610336A2 (pt) 2010-06-15
ZA200710145B (en) 2008-11-26
CN101163698B (zh) 2011-05-18
CA2605758A1 (en) 2006-11-02
JP5113039B2 (ja) 2013-01-09
RU2397981C2 (ru) 2010-08-27
EP1874762B1 (de) 2009-01-14
BRPI0610336B8 (pt) 2021-05-25
US20080293943A1 (en) 2008-11-27
EP1874762A1 (de) 2008-01-09
AU2006239569A1 (en) 2006-11-02
CY1108904T1 (el) 2012-05-23
DE102005019670A1 (de) 2006-11-02
KR20080013920A (ko) 2008-02-13
BR122020011626B1 (pt) 2021-01-19
PT1874762E (pt) 2009-04-16
CN101163698A (zh) 2008-04-16
PL1874762T3 (pl) 2009-05-29
RU2007143504A (ru) 2009-06-10

Similar Documents

Publication Publication Date Title
DK1874762T3 (da) Fremgangsmåde til fremstilling af 5-(4-[4-(5-cyano-3-indolyl)-butyl]-1-piperazinyl)-benzofuran-2-carboxamid
GB0418900D0 (en) Novel salt forms
NO20061420L (no) 3-[(2-{4-Heksyloksykarbonylamino-Imino-metyl)-Fenylamino]-Metyl}-1-Metyl-1H-Benzimidazol-5-Karbonyl)-Pyridin-2-yl-Amino]-Propansyre Etylester Metansulfonat og
NO20073663L (no) Tiazol-4-karboksamid-derivater som mGluR5 antagonister
ME01395B (me) Postupak za izradu (1s)-4,5-dimetoksi-1-(metilaminometil)benzociklobutanai njegovih aditivnih soli kiselina kao i njegov a primena za sintezu ivabradina i njegovih farmaceutski prihvatljivih aditivnih soli kiselina
EA200870586A1 (ru) 3-(1,3-бензодиоксол-5-ил)-6-(4-циклопропилпиперазин-1-ил)пиридазин, его соли и сольваты и его применение в качестве антагониста н3 рецептора гистамина
DK2091948T3 (da) Nye inhibitorer af glutaminylcyclase
ATE388146T1 (de) 1-isopropyl-2-oxo-1,2-dihydropyridin-3- carbonsäureamidderivate mit agonistischer wirkung am 5-ht4-rezeptor
MXPA05006907A (es) Compuestos diazoicos cationicos, composiciones que los contienen como colorante directo, procedimiento de coloracion de fibras queratinicas y dispositivo.
DE602005002475D1 (de) Verfahren zur vorbereitung von telithromycin
TW200637822A (en) Process for the preparation of a 2-pyridylethylcarboxamide derivative
BRPI0516904A (pt) processo para a preparação de um derivado de 2-etilaminopiridina e composto
NO20074311L (no) Kinazolinderivat med tyrosinkinase-inhiberendeaktivitet
EA200701470A1 (ru) Способы получения производных 4-(фенокси-5-метилпиримидин-4-илокси)пиперидин-1-карбоновой кислоты и родственных соединений
ATE529181T1 (de) Neuartiges dispersionsmittel und zusammensetzungen daraus
IS7978A (is) Aðferð til að framleiða súr viðbótarsölt af fjölsýrðum basískum samböndum
EA200701260A1 (ru) Циннаматные соли бета-2 адренергического агониста
GEP20084494B (en) New heterocyclic carboxylic acid amide derivatives
MXPA05013751A (es) Procedimiento e intermediarios para la preparacion de 3-(amino)-3-ciclobutilmetil-2-hidroxi-propionamida o sus sales.
TNSN07439A1 (en) Derivatives of,4,5 - diarylpyrrole, preparation method thereof and use of same in therapeutics
RS53062B (en) PREPARATION PROCESS 4 - [(1,6-Dihydro-6-oxo-2-pyrimidinyl) AMINO BENZONITRILA
JP2010527364A5 (da)
EA201001252A1 (ru) Способ получения производных 3,6-дигидро-1,3,5-триазина
NO20073213L (no) Fremgangsmate for fremstilling av tiofenglykosidderivater
DK2265580T3 (da) Hidtil ukendt fremgangsmåde til fremstillingen af sulfonylpyrroler som HDAC-inhibitorer